If CD81 gene expression could be controlled by ON or OFF Pax5-expression, Pax5-mediated CD81 regulation may be useful for the treatment of B cell lymphoma using anti-CD81 antibodies. This evidence concerns the gene CD81 and B-cell non-Hodgkin lymphoma.